Univest
Univest
  • Markets

3 Batteries and Defence Electronics Maker, Hospitals Chain and Generic Medicines Maker Stocks With a Strong Future Roadmap: HBL Engineering, Apollo Hospitals Enterprise and Dr. Reddy’s Laboratories

  • November 17, 2026
  • Posted by: Lakshit Sharma
  • Category: Best Stocks
No Comments
3 Batteries and Defence Electronics Maker, Hospitals Chain and Generic Medicines Maker Stocks With a Strong Future Roadmap: HBL Engineering, Apollo Hospitals Enterprise and Dr. Reddy's Laboratories

HBL Engineering, Apollo Hospitals Enterprise and Dr. Reddy’s Laboratories: ROE of 11.1% to 36.8% and FY22 to FY26 revenue CAGR of 12.3% to 28.0%. Prices as of 16 Nov 2026.

Quick Answer

The three lamp, power tower and software stocks to watch are HBL Engineering, Apollo Hospitals Enterprise and Dr. Reddy’s Laboratories. Their return on equity ranges from 11.1% to 36.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 12.3% to 28.0%. HBL Engineering leads on both return on equity at 36.8% and revenue growth at 28.0% a year. Prices are based on the 16 November 2026 close, and this article is educational, not investment advice.

Lamp, power tower and software stocks give investors a way to track businesses that sit close to everyday demand in India. HBL Engineering, Apollo Hospitals Enterprise and Dr. Reddy’s Laboratories cover a batteries and defence electronics maker, a hospitals chain and a generic medicines maker.

This list covers three lamp, power tower and software stocks with complete current figures: HBL Engineering, Apollo Hospitals Enterprise and Dr. Reddy’s Laboratories. Every figure comes from the latest reported financials and the 16 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • What Are Lamp, Power Tower and Software Stocks?
  • Lamp, Power Tower and Software Stocks at a Glance
  • Why Do Lamp, Power Tower and Software Stocks Have a Strong Roadmap in India?
  • Why HBL Engineering Features Among These Lamp, Power Tower and Software Stocks
  • Why Apollo Hospitals Enterprise Features Among These Lamp, Power Tower and Software Stocks
  • Why Dr. Reddy’s Laboratories Features Among These Lamp, Power Tower and Software Stocks
  • HBL Engineering vs Apollo Hospitals Enterprise vs Dr. Reddy’s Laboratories on Key Financials
  • Key Risks to Check Before Investing in Lamp, Power Tower and Software Stocks
  • Final Thoughts on Lamp, Power Tower and Software Stocks
    • What are lamp, power tower and software stocks?
    • Which lamp, power tower and software stocks are covered in this list?
    • Why do lamp, power tower and software stocks have a strong future roadmap in India?
    • How has HBL Engineering performed financially?
    • How has Apollo Hospitals Enterprise performed financially?
    • How has Dr. Reddy’s Laboratories performed financially?
    • What risks should investors check before buying lamp, power tower and software stocks?
    • Is this list of lamp, power tower and software stocks investment advice?

What Are Lamp, Power Tower and Software Stocks?

Lamp, power tower and software stocks are listed companies that make industrial batteries, defence electronics and railway safety systems, run large multi speciality hospitals and pharmacies, and make generic medicines and ingredients for India and global markets. Their earnings depend on defence and rail orders, patient volumes and medicine demand.

Lamp, Power Tower and Software Stocks at a Glance

Company CMP (Rs) Market Cap (Rs Cr) P/E Industry P/E ROE (%) D/E
HBL Engineering 780.45 22,507 28.8 36.9 36.8 0.03
Apollo Hospitals Enterprise 8,771 110,757 51.0 59.6 20.5 0.90
Dr. Reddy’s Laboratories 1,377.9 103,667 32.6 36.0 11.1 0.20

On valuation, all three trade at a P/E below their industry P/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing lamp, power tower and software stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.

Why Do Lamp, Power Tower and Software Stocks Have a Strong Roadmap in India?

Lamp, power tower and software stocks have a strong roadmap in India because rising defence and railway spending, rising need for quality hospital care and wider access to quality medicines keep widening the market for these companies.

  • Defence batteries. Defence and rail need advanced systems.
  • Hospitals. Families seek quality specialist care.
  • Generic medicines. Patients need affordable medicines.

Why HBL Engineering Features Among These Lamp, Power Tower and Software Stocks

Among the lamp, power tower and software stocks on this list, HBL Engineering, formerly HBL Power Systems, makes specialised batteries, defence electronics, railway safety systems, and electronics for aerospace and industrial use.

The company has a return on equity of 36.8%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 22,507 crore. The stock trades at a P/E of 28.8, below the industry P/E of 36.9.

Revenue rose from Rs 1,251 crore in FY22 to Rs 3,362 crore in FY26, a compound annual growth rate of 28.0%. Net profit grew from Rs 93.7 crore in FY22 to Rs 814 crore in FY26, which works out to a compound annual growth rate of 71.7%. In the June 2026 quarter, revenue grew 6.0% year on year to Rs 659 crore.

Roadmap: The company has grown its defence electronics and railway safety businesses, including systems for collision avoidance, and is expanding its battery lines. Orders from railways and defence customers provide a long runway.

What to watch: Monitor large railway and defence orders and their execution schedules.

Why Apollo Hospitals Enterprise Features Among These Lamp, Power Tower and Software Stocks

Among the cell maker, hospital chain and generics shares on this list, Apollo Hospitals Enterprise is India’s largest private healthcare group, running a network of hospitals along with a pharmacy chain, diagnostics, primary care clinics and a digital health platform.

Revenue rose from Rs 14,741 crore in FY22 to Rs 25,420 crore in FY26, a compound annual growth rate of 14.6%. Net profit grew from Rs 1,101 crore in FY22 to Rs 2,003 crore in FY26, which works out to a compound annual growth rate of 16.1%.

In the June 2026 quarter, revenue grew 20.6% year on year to Rs 7,092 crore, while net profit rose 38.4% to Rs 610 crore. The company has a return on equity of 20.5%, a debt to equity ratio of 0.90 and a market capitalisation of Rs 110,757 crore. The stock trades at a P/E of 51.0, below the industry P/E of 59.6.

Roadmap: The company is adding hospital beds in proven cities while growing its pharmacy and digital businesses, which broaden its reach beyond inpatient care. A strong brand in complex treatment and a wide patient base support steady occupancy.

What to watch: Track bed additions and occupancy and the growth of the pharmacy and digital health businesses.

Why Dr. Reddy’s Laboratories Features Among These Lamp, Power Tower and Software Stocks

Among the three companies on this list, Dr. Reddy’s Laboratories is a Hyderabad-based pharmaceutical company that makes generics, active ingredients and branded products for India and global markets, with a large presence in North America and Europe.

Revenue rose from Rs 22,030 crore in FY22 to Rs 35,059 crore in FY26, a compound annual growth rate of 12.3%. Net profit grew from Rs 2,182 crore in FY22 to Rs 4,158 crore in FY26, which works out to a compound annual growth rate of 17.5%.

The company has a return on equity of 11.1%, a debt to equity ratio of 0.20 and a market capitalisation of Rs 103,667 crore. The stock trades at a P/E of 32.6, below the industry P/E of 36.0.

Roadmap: The company is widening its product pipeline with complex generics, biosimilars and consumer health, while its domestic business adds steady growth. Investment in research supports a stream of new launches.

What to watch: Monitor launches of complex generics and the progress of biosimilar programmes.

HBL Engineering vs Apollo Hospitals Enterprise vs Dr. Reddy’s Laboratories on Key Financials

The table below sets the three lamp, power tower and software stocks side by side on revenue, profit and margin, using reported figures.

Company FY22 Revenue (Rs Cr) FY26 Revenue (Rs Cr) Revenue CAGR (FY22-FY26) FY26 Net Profit (Rs Cr) FY26 Net Margin
HBL Engineering 1,251 3,362 28.0% 814 24.2%
Apollo Hospitals Enterprise 14,741 25,420 14.6% 2,003 7.9%
Dr. Reddy’s Laboratories 22,030 35,059 12.3% 4,158 11.9%

HBL Engineering posts the highest return on equity in this group at 36.8%. Dr. Reddy’s Laboratories has the largest FY26 revenue at Rs 35,059 crore, and HBL Engineering shows the fastest revenue growth with a 28.0% compound annual rate. A useful habit with lamp, power tower and software stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in Lamp, Power Tower and Software Stocks

Every theme carries risks that deserve a check before any decision. For these lamp, power tower and software stocks, the main points are: Long-term cell maker, hospital chain and generics shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

  • Order timing. Defence and space orders can shift between periods.
  • Capacity ramp up. New hospitals take time to fill beds and reach full returns.
  • Regulatory approvals. Plant inspections and approvals can affect supplies.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter lamp, power tower and software stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Lamp, Power Tower and Software Stocks

Lamp, power tower and software stocks work best when investors track growth, valuation and return on equity side by side. HBL Engineering, Apollo Hospitals Enterprise and Dr. Reddy’s Laboratories each have a clear plan to grow. Based on the 16 November 2026 close, HBL Engineering trades at Rs 780.45, Apollo Hospitals Enterprise at Rs 8,771 and Dr. Reddy’s Laboratories at Rs 1,377.9. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these lamp, power tower and software stocks to a watchlist.

Download the Univest iOS App or Univest Android App to track lamp, power tower and software stocks, set price alerts and get research-backed stock ideas.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

What are lamp, power tower and software stocks?

Ans. Lamp, power tower and software stocks are listed companies that make industrial batteries, defence electronics and railway safety systems, run large multi speciality hospitals and pharmacies, and make generic medicines and ingredients for India and global markets. Their earnings depend on defence and rail orders, patient volumes and medicine demand. This list looks at three of them, HBL Engineering, Apollo Hospitals Enterprise and Dr. Reddy’s Laboratories, using reported FY22 to FY26 financials and the 16 November 2026 closing prices.

Which lamp, power tower and software stocks are covered in this list?

Ans. This list covers HBL Engineering, Apollo Hospitals Enterprise and Dr. Reddy’s Laboratories. Based on the 16 November 2026 close, HBL Engineering traded at Rs 780.45, Apollo Hospitals Enterprise at Rs 8,771 and Dr. Reddy’s Laboratories at Rs 1,377.9. Their return on equity ranges from 11.1% to 36.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 12.3% to 28.0%.

Why do lamp, power tower and software stocks have a strong future roadmap in India?

Ans. Lamp, power tower and software stocks have a strong roadmap in India because rising defence and railway spending, rising need for quality hospital care and wider access to quality medicines keep widening the market for these companies. The main drivers are as follows. Defence batteries. Defence and rail need advanced systems. Hospitals. Families seek quality specialist care. Generic medicines. Patients need affordable medicines. Together these factors give the companies on this list a visible path for growth over the coming years.

How has HBL Engineering performed financially?

Ans. Revenue rose from Rs 1,251 crore in FY22 to Rs 3,362 crore in FY26, a compound annual growth rate of 28.0%. Net profit grew from Rs 93.7 crore in FY22 to Rs 814 crore in FY26, which works out to a compound annual growth rate of 71.7%. In the June 2026 quarter, revenue grew 6.0% year on year to Rs 659 crore. The company has a return on equity of 36.8%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 22,507 crore. The stock trades at a P/E of 28.8, below the industry P/E of 36.9. Looking ahead, the company has grown its defence electronics and railway safety businesses, including systems for collision avoidance, and is expanding its battery lines. Orders from railways and defence customers provide a long runway.

How has Apollo Hospitals Enterprise performed financially?

Ans. Revenue rose from Rs 14,741 crore in FY22 to Rs 25,420 crore in FY26, a compound annual growth rate of 14.6%. Net profit grew from Rs 1,101 crore in FY22 to Rs 2,003 crore in FY26, which works out to a compound annual growth rate of 16.1%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 7,092 crore, while net profit rose 38.4% to Rs 610 crore. The company has a return on equity of 20.5%, a debt to equity ratio of 0.90 and a market capitalisation of Rs 110,757 crore. The stock trades at a P/E of 51.0, below the industry P/E of 59.6. Looking ahead, the company is adding hospital beds in proven cities while growing its pharmacy and digital businesses, which broaden its reach beyond inpatient care. A strong brand in complex treatment and a wide patient base support steady occupancy.

How has Dr. Reddy’s Laboratories performed financially?

Ans. Revenue rose from Rs 22,030 crore in FY22 to Rs 35,059 crore in FY26, a compound annual growth rate of 12.3%. Net profit grew from Rs 2,182 crore in FY22 to Rs 4,158 crore in FY26, which works out to a compound annual growth rate of 17.5%. The company has a return on equity of 11.1%, a debt to equity ratio of 0.20 and a market capitalisation of Rs 103,667 crore. The stock trades at a P/E of 32.6, below the industry P/E of 36.0. Looking ahead, the company is widening its product pipeline with complex generics, biosimilars and consumer health, while its domestic business adds steady growth. Investment in research supports a stream of new launches.

What risks should investors check before buying lamp, power tower and software stocks?

Ans. Investors should check a few risks before buying lamp, power tower and software stocks. Order timing. Defence and space orders can shift between periods. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Regulatory approvals. Plant inspections and approvals can affect supplies. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of lamp, power tower and software stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 16 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.



Apollo Hospitals Enterprise Best Stocks cell maker Dr Reddy's Laboratories HBL Engineering hospital chain and generics shares lamp power storage and electronics power tower and software stocks specialist care and formulations stocks

Leave a Reply Cancel reply